Plain-English translation of NCT06960577 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Urinary Bladder Neoplasms research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , an immune-boosting medication, combined with chemotherapy in patients with muscle-invasive bladder cancer who are planning to have surgery to remove their bladder. The study will give patients the medication before their operation to see if this approach helps prevent the cancer from coming back and improves survival.
Muscle-invasive bladder cancer is serious, and even after surgery, cancer can return in many patients. Researchers believe that giving this medication before surgery—when combined with chemotherapy—might help the immune system fight any remaining cancer cells and improve long-term outcomes.
You likely qualify if…
You likely don't qualify if…
You would receive the medication along with one of two chemotherapy regimens (your doctor will choose which one is best for you) before your scheduled bladder removal surgery. During this treatment period, you will have regular clinic visits for blood tests, scans, and check-ups to monitor how well the treatment is working and watch for side effects. After completing the medication course, you will have your planned surgery and then continue to be monitored during recovery and follow-up.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Australia